Global Differences in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial

Tromp, J; Claggett, BL; Liu, JK; Jackson, AM; Jhund, PS; Kober, L; Widimsky, J; Boytsov, SA; Chopra, VK; Anand, IS; Ge, JB; Chen, CH; Maggioni, AP; Martinez, F; Packer, M; Pfeffer, MA; Pieske, B; Redfield, MM; Rouleau, JL; Van Veldhuisen, DJ; Zannad, F; Zile, MR; Rizkala, AR; Inubushi-Molessa, A; Lefkowitz, MP; Shi, VC; McMurray, JJV; Solomon, SD; Lam, CSP

Lam, CSP (corresponding author), Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore.; Solomon, SD (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.

CIRCULATION-HEART FAILURE, 2021; 14 (4):

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF) is a global public health problem with important regional differences. We investiga......

Full Text Link